Exam Flashcards
(154 cards)
ASA II
Mild to moderate systemic disease that does not interfere with daily activity
significant health risk factor such as smoking, alcohol abuse, obesity
Patients that need prophylactic antibiotics, modification to treatment, requiring sedation
can perform normal activities without distress
ASA III
Patients with moderate to severe systemic disease that is not incapacitating but limits normal daily activities
modified dental treatment often required
ASA IV
Incapacitating severe systemic disease that is a constant threat to life.
Elective dental treatment must be postponed until ASA III
Type 1 allergy
Atopic reactions and anaphylaxis
Itching of the palate, nausea, Substernal pressure, Shortness of breath, hypotension
Swelling requires epi and O2, and diphenhydramine 50mg
Type III allergy
White, erythematous or ulcerative lesions
Topical treatment, diphenhydramine syrup, Kenalog in orabase (oracort)
Type IV allergy
contact dermatitis, transplant rejection
Topical treatment of benzydamine rinse or Oracort
The most common drugs with allergic potential
Penicillins ASA Codeine barbiturates Esther local anesthetics LA preservatives (paraben or bisulfite)
Penicillin allergy prevalence
5-10% of patients react
anaphylaxis in 0.04-0.2%
Analgesic allergy
ASA (and other NSAIDs) can cause severe reactions in asthmatics
non-allergic reactions: GI upset/bleeds, heartburn
Codiene allergy
Nausea, emesis, constipation
Non-allergic
Two main kinds of LA agents
Amides and Esters
Do not cross-react in allergy situations
Highest incidence of LA allergy
Procaine (PABA ester)
Cross-reaction with Latex allergy
Banana’s
Type I reactions possible but Type IV more common
Peanut Allergy
Avoid Coe-Pak
Formaldehyde allergy
Avoid tissue adhesives such as histoacryl
SSRI Side effect
Decrease platelet function Avoid perscribing ASA, NSAIDs, steroids Maximum 2 cartridges of 1:100,000 epi per visit maybe? - unclear, keep in mind Reduce sedation dosage Erythromycin action inhibited
Asthma precautions
Do not perscribe NSAIDs as severe reaction may develop, especially if they have nasal polyps
Bisphosphonate risk factors
Risk factors for MRONJ - 65yo+, periodontitis, 2+ years on bisphosphonate, smoking, denture wearing, diabetes
Symptoms of MRONJ
pain soft tissue swelling and infection loosening of teeth drainage and exposed bone numbness may be asymptomatic for weeks or months
Maximum dose of epi for a healthy patient
0.2mg - 11 carpules of 1:100,000 (0.018mg per carpule)
Maximum dose of epi for CVD patient
0.036mg - 2 cartridges of 1:100,000
Levonordefrin
Alternative to epi in LA
Avoid in CVD patients
LA reccomendation for longer procedures in patients with CVD
bupivocaine (marcaine) 1:200,000 epi
contraindications for epi
unstable angina recent MI (1 month) recent stroke (6 months) recent bypass surgery (3 months) severe hypertension uncontrolled uncontrolled arrhythmias uncontrolled hyperthyroidism